Dermata Therapeutics, Inc.
DRMA
$1.21
-$0.02-1.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -36.46% | -7.67% | 61.27% | -28.03% | -33.32% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 60.79% | -- | -- | -- | -- |
| Prepaid Expenses | -36.78% | -49.39% | 61.98% | 165.11% | -46.56% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 293.97% | 199.08% | 505.56% | -32.50% | 300.00% |
| Total Current Assets | -30.94% | -5.06% | 55.06% | -23.63% | -33.63% |
|
|
|||||
| Total Current Assets | -30.94% | -5.06% | 55.06% | -23.63% | -33.63% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -28.73% | -5.06% | 55.06% | -23.63% | -33.63% |
|
|
|||||
| Total Accounts Payable | 251.78% | -30.92% | 1.63% | 9.60% | -70.35% |
| Total Accrued Expenses | -2.85% | -37.75% | 79.30% | 7.39% | -53.18% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 74.15% | -35.83% | 47.61% | 8.28% | -62.04% |
|
|
|||||
| Total Current Liabilities | 74.15% | -35.83% | 47.61% | 8.28% | -62.04% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 74.15% | -35.83% | 47.61% | 8.28% | -62.04% |
|
|
|||||
| Common Stock & APIC | 0.05% | 2.56% | 5.48% | 0.05% | 0.02% |
| Retained Earnings | -3.95% | -2.52% | -2.61% | -2.43% | -2.50% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -45.62% | 3.05% | 57.15% | -29.46% | -23.10% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.62% | 3.05% | 57.15% | -29.46% | -23.10% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.62% | 3.05% | 57.15% | -29.46% | -23.10% |
|
|
|||||